Target
IL10
3 abstracts
Abstract
Circulating immune protein biomarkers of early response and resistance in patients with metastatic HER-2–negative esophagogastric cancer (mEGC) treated with pembrolizumab and chemotherapy.Org: Olink Proteomics AB,
Abstract
Comprehensive characterization of androgen receptor expression in breast cancer.Org: Caris Life Sciences, Irving, TX, City of Hope National Medical Center, Washington University School of Medicine in St Louis, Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI,
Abstract
Determinants of racial disparities in immune-related adverse events (irAE) with checkpoint inhibition (ICI) in melanoma.Org: New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, University of Texas MD Anderson Cancer Center, NYU Grossman School of Medicine, Department of Population Health,